BRIEF: Financial asset gains lift XtalPi to profit, as revenue triples
AI drug discovery company XtalPi Holdings Ltd. (2228.HK) announced on Tuesday it expects to report net profit of 100 million yuan ($14 million) or more for 2025, reversing a 1.52…
BRIEF: InSilico gets CSRC nod for Hong Kong IPO
AI drug discovery platform InSilico Medicine Cayman TopCo has been approved by China’s securities watchdog for a Hong Kong IPO, clearing a key hurdle in its stalled listing. According to…
